RDInvesting Provides Investors with Free In-Depth Equity Reports on IRBT, MCHP, MSCC and XLNXadmin
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
iRobot Corporation (NASDAQ: IRBT) shares gained 1.30 percent to close at $29.63 a share Thursday. The stock traded between $29.59 and $30.53 on volume of 615,287 shares traded. Analysts at JPMorgan have recently upgraded the company’s rating to “neutral” from “underweight”. Shares of iRobot have gained approximately 58.0 percent year-to-date.
Find out more about iRobot including full access to the free equity report at:
Microchip Technology Inc. (NASDAQ: MCHP) shares declined 0.43 percent to close at $41.97 a share Thursday. The stock traded between $41.96 and $42.67 on volume of 1.42 million shares traded. Analysts at Drexel Hamilton have recently initiated coverage on the company with a “buy” rating and a price target of $50.00. Shares of Microchip Technology have gained approximately 28.0 percent year-to-date.
Find out more about Microchip Technology including full access to the free equity report at:
Microsemi Corporation (NASDAQ: MSCC) shares declined 1.20 percent to close at $23.03 a share Thursday. The stock traded between $22.91 and $23.38 on volume of 713,882 shares traded. Analysts at Drexel Hamilton have recently initiated coverage on the company with a “hold” rating and a price target of $26.00. Shares of Microsemi have gained approximately 10.0 percent year-to-date.
Find out more about Microsemi including full access to the free equity report at:
Xilinx, Inc. (NASDAQ: XLNX) shares gained 0.81 percent to close at $43.41 a share Thursday. The stock traded between $43.31 and $44.00 on volume of 3.37 million shares traded. Analysts at Nomura have recently upgraded the company’s rating to “buy” from “neutral”. Shares of Xilinx have gained approximately 21.0 percent year-to-date.
Find out more about Xilinx including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Posted: December 13th, 2013 under ACCESSWIRE.